Genetic Interaction Between APOE and PRNP in Alzheimer's and Creutzfeldt-Jakob Diseases
Author Information
Author(s): Calero Olga, Bullido María J., Clarimón Jordi, Frank-García Ana, Martínez-Martín Pablo, Lleó Alberto, Rey María Jesús, Rábano Alberto, Blesa Rafael, Gómez-Isla Teresa, Valdivieso Fernando, de Pedro-Cuesta Jesús, Ferrer Isidro, Calero Miguel
Primary Institution: Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain
Hypothesis
Is there a genetic interaction between APOE and PRNP that affects the risk of developing Alzheimer's disease and Creutzfeldt-Jakob disease?
Conclusion
The study found that the presence of the APOE ε4 allele increases the risk of developing Alzheimer's disease, while homozygosity at the PRNP gene increases the risk for Creutzfeldt-Jakob disease, with significant interactions between these genes.
Supporting Evidence
- The presence of the APOE ε4 allele is associated with a higher risk of developing Alzheimer's disease.
- Homozygosity at the PRNP gene constitutes a risk for sporadic CJD.
- Statistically significant associations were found for the other gene in strata at higher previous risk.
- Synergy factor analysis showed a significant interaction between APOE and PRNP in both diseases.
Takeaway
This study looked at how two genes, APOE and PRNP, work together to affect the risk of getting Alzheimer's and another brain disease. They found that having certain versions of these genes can make you more likely to get these diseases.
Methodology
The study analyzed genotypes of 474 Alzheimer's patients, 175 sporadic CJD patients, and 335 control subjects using logistic regression to assess genotype distribution and risk associations.
Potential Biases
Potential bias due to population stratification and the small number of cases in some strata.
Limitations
The Alzheimer's cases were diagnosed clinically without anatomopathological confirmation, and the study was limited to a Spanish population.
Participant Demographics
Participants included 474 Alzheimer's patients, 175 sporadic CJD patients, and 335 control subjects, all Caucasians of Spanish origin.
Statistical Information
P-Value
p<0.0001
Confidence Interval
95% CI: 3.16–6.45
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website